Low-dose Cytosine arabinoside; disease free survival and overall survival in the elderly patients with Acute Myeloid Leukemia

被引：0
作者：
Sanaat, Zohreh [1 ]
Najafi, Amin [1 ]
机构：
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Ghazi Tabatabae Hosp, Tabriz, Iran
来源：
PAKISTAN JOURNAL OF MEDICAL SCIENCES | 2011年 / 27卷 / 05期
关键词：
Acute myeloid leukemia; Low-dose Cytosine arabinoside; Disease-free survival; Overall survival; Flowcytometry; Elderly AML; ACUTE NONLYMPHOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; ARA-C; CYTARABINE; THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objectives: The median age of the patients with acute myeloid leukemia (AML) is 65 years. Studies have revealed that the prognosis of the elderly patients (over 60 years) is not satisfying. The aim of this study was to evaluate the survival of AML patients being treated with Low-dose Cytosine arabinoside. Methodology: In this cross-sectional study, 20 AML patients treated with Low-dose Cytosine arabinoside. Disease free survival and overall five-year survival ratios were identified. Results: In this study there were 11 males (55%) and nine female (45%) with a mean age of 63.3 +/- 18.4 years. The median of disease free survival was 12.4 months and five-year survival was 1.7 years. Conclusion: Apparently disease-free survival and overall five-year survival in the AML patients being treated with Low-dose Cytosine arabinoside are similar to that of cases being treated with intense chemotherapy regimens.
引用
收藏
页码：1211 / 1213
页数：3
相关论文
共 50 条
[31]   High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia [J].
Wu, Lina ;
Xia, Miaoran ;
Sun, Xiaoping ;
Han, Xin ;
Zu, Youli ;
Jabbour, Elias J. ;
You, M. James ;
Lin, Pei ;
Li, Shaoying ;
Xu, Jie ;
Han, Haibo ;
Bueso-Ramos, Carlos E. ;
Medeiros, L. Jeffrey ;
Qiu, Xiaoyan ;
Yin, C. Cameron .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (04) :449-459
[32]   Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia [J].
Peipert, John Devin ;
Eficace, Fabio ;
Pierson, Renee ;
Loefgren, Christina ;
Cella, David ;
He, Jianming .
JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) :935-939
[33]   Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy [J].
Jorge E. Cortes ;
Florian H. Heidel ;
Walter Fiedler ;
B. Douglas Smith ;
Tadeusz Robak ;
Pau Montesinos ;
Anna Candoni ;
Brian Leber ;
Mikkael A. Sekeres ;
Daniel A. Pollyea ;
Roxanne Ferdinand ;
Weidong Wendy Ma ;
Thomas O’Brien ;
Ashleigh O’Connell ;
Geoffrey Chan ;
Michael Heuser .
Journal of Hematology & Oncology, 13
[34]   Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy [J].
Cortes, Jorge E. ;
Heidel, Florian H. ;
Fiedler, Walter ;
Smith, B. Douglas ;
Robak, Tadeusz ;
Montesinos, Pau ;
Candoni, Anna ;
Leber, Brian ;
Sekeres, Mikkael A. ;
Pollyea, Daniel A. ;
Ferdinand, Roxanne ;
Ma, Weidong Wendy ;
O'Brien, Thomas ;
O'Connell, Ashleigh ;
Chan, Geoffrey ;
Heuser, Michael .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[35]   CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - THE ROLE AND PLACE OF HIGH-DOSE REGIMENS [J].
HIDDEMANN, W .
ANNALS OF HEMATOLOGY, 1991, 62 (04) :119-128
[36]   Patterns of Care and Survival for Elderly Acute Myeloid Leukemia—Challenges and Opportunities [J].
Abhishek A. Mangaonkar ;
Mrinal M. Patnaik .
Current Hematologic Malignancy Reports, 2017, 12 :290-299
[37]   Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity [J].
Lane, Steven ;
Gill, Devinder ;
McMillan, Nigel A. J. ;
Saunders, Nicholas ;
Murphy, Rachel ;
Spurr, Terrence ;
Keane, Colm ;
Fan, Helen Mar ;
Mollee, Peter .
LEUKEMIA & LYMPHOMA, 2012, 53 (06) :1077-1083
[38]   The impact of kidney function on survival in elderly patients diagnosed with acute myeloid leukemia [J].
Pulko, Nejc ;
Petreski, Tadej ;
Hauptman, Jasmina ;
Piko, Nejc ;
Roskar, Zlatko ;
Bevc, Sebastjan .
CLINICAL NEPHROLOGY, 2021, 96 (07) :S31-S35
[39]   Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine [J].
Grigg, AP ;
Reynolds, J ;
McQuillan, A ;
Juneja, SK ;
Di Iulio, J ;
Hui, C ;
Smith, C ;
Kimber, R ;
Bradstock, KF .
LEUKEMIA & LYMPHOMA, 2005, 46 (03) :367-375
[40]   Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Gattermann, Norbert ;
Germing, Ulrich ;
Sanz, Guillermo ;
List, Alan F. ;
Gore, Steven ;
Seymour, John F. ;
Dombret, Herve ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :562-569
12345